2013

Nicolás Manito: ”the new mechanical hearts save transplants”

Heart failure is the leading cause of admission to hospital and one of the health problems that is growing as people live longer. The head of the Heart Failure and Cardiac Transplant Unit at the Bellvitge University Hospital and researcher at the Cardiovascular Diseases group at IDIBELL, Nicolás Manito, spoke about heart failure on May […]

Nicolás Manito: ”the new mechanical hearts save transplants” Read More »

The neuroscientist Josef Rauschecker explains at CosmoCaixa the evolution of speech and music: from apes to humans

Rauschecker leads the integrated neuroscience laboratory and Cognition at the University of Georgetown. His research focuses on understanding the neurophysiological mechanisms that differentiate us from other primate species and that have allowed us to develop throughout the evolution of music and speech. In this talk we will know the neural circuits in humans and monkeys

The neuroscientist Josef Rauschecker explains at CosmoCaixa the evolution of speech and music: from apes to humans Read More »

Manel Esteller, BIAL Foundation Distinction for his work in cancer genetics

Manel Esteller, Director of the Cancer Epigenetics and Biology Program at IDIBELL, Professor of Genetics at the University of Barcelona and ICREA Research Professor has been awarded with a BIAL Foundation Distinction in its eighth edition. The international honour distinguishes a research work which content constitutes a significant contribution in the field of Health Sciences.

Manel Esteller, BIAL Foundation Distinction for his work in cancer genetics Read More »

Diego Viasus awarded the Extraordinary Doctorate Prize of the Faculty of Medicine of the UB

The PhD thesis of Diego Viasus researcher at Infections of the respiratory tract and in Immunocomproimised Patients research group at IDIBELL has won two awards. On one hand, has received the Extraordinary Doctorate Award from the Faculty of Medicine of the University of Barcelona and on the other, the Gabriel Rufí Prize for the best

Diego Viasus awarded the Extraordinary Doctorate Prize of the Faculty of Medicine of the UB Read More »

José Luis Hernández: ”We have designed two antibodies that block S100 proteins and we’ve observed that slow tumors growth”

The laboratory of José Luis Hernández at the Biomed division, LEITAT Technology Center of Barcelona works in the clinical application of two antibodies designed by them to block proliferative function of extracellular S100 proteins. Hernandez explained his research on April 26 at a conference framed at IDIBELL seminars cycle. “We designed two antibodies that block

José Luis Hernández: ”We have designed two antibodies that block S100 proteins and we’ve observed that slow tumors growth” Read More »

IDIBELL license to Minoryx a patent of a product to treat a rare neurodegenerative disease

IDIBELL has signed a licensing agreement with the Catalan biotechnology company Minoryx of a patent for the treatment of X-linked adrenoleukodystrophy, a rare serious neurodegenerative disease, which has no effective treatment. The Neurometabolic Diseases group led by ICREA researcher Aurora Pujol, has developed an animal model to study this disease. Studies using this model have

IDIBELL license to Minoryx a patent of a product to treat a rare neurodegenerative disease Read More »

‘Dark genome’ is involved in Rett Syndrome

Researchers at the Epigenetics and Cancer Biology Program at IDIBELL led by Manel Esteller, ICREA researcher and professor of genetics at the University of Barcelona, have described alterations in noncoding long chain RNA sequences (lncRNA) in Rett syndrome. These molecules act as supervisor agents responsible of ‘switch on’ or ‘switch off’ other genes in our

‘Dark genome’ is involved in Rett Syndrome Read More »

Cedric Notredame: “We want to understand under what pressure evolves long noncoding RNA”

According to the ENCODE‘s latest update in the human genome there are about 10,000 long sequences of RNA that do not code for any protein. Cedric Notredame’s lab at the Center for genomic Regulation (CRG) tries to detect these molecules not only in humans but also in other species to understand their functionality. Cedric Notredame

Cedric Notredame: “We want to understand under what pressure evolves long noncoding RNA” Read More »

Piero Crespo: “We look for site-specific inhibitors and that block protein-protein interactions”

The field of study of Piero Crespo at the Institute of Biomedicine and Biotechnology of Cantabria (IBBTEC) is the regulation of Ras-ERK signals. On April 19, explained the latest developments of their research at a conference framed in IDIBELL seminar series. His work focuses on the study of the mechanisms of Ras regulation in particular

Piero Crespo: “We look for site-specific inhibitors and that block protein-protein interactions” Read More »

Scroll to Top